Literature DB >> 35925211

[Bullous drug reaction after pembrolizumab administration: two case reports].

L Golle1, C Michl2, B Kreft2.   

Abstract

Severe, blistering, adverse drug reactions involving the skin include Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). Allopurinol, anticonvulsants, sulphonamide antibiotics and non-steroidal anti-inflammatory drugs in the oxicam class have been repeatedly described as triggers. Increasingly, immunotherapies are also coming into focus as triggers of severe skin reactions. Two patients with bullous skin symptoms after administration of the checkpoint inhibitor pembrolizumab are presented. As the clinical picture does not always allow an unequivocal classification, a histological assessment is often indispensable.
© 2022. The Author(s).

Entities:  

Keywords:  Bullous drug reaction; Checkpoint-inhibitor; Histology; Pembrolizumab; Toxic epidermal necrolysis

Year:  2022        PMID: 35925211     DOI: 10.1007/s00105-022-05018-0

Source DB:  PubMed          Journal:  Dermatologie (Heidelb)        ISSN: 2731-7005


  2 in total

1.  Pembrolizumab induced toxic epidermal necrolysis.

Authors:  Rohit Kumar; Shruti Bhandari
Journal:  Curr Probl Cancer       Date:  2019-05-14       Impact factor: 3.187

2.  Stevens-Johnson syndrome and toxic epidermal necrolysis-like reactions to checkpoint inhibitors: a systematic review.

Authors:  Nolan J Maloney; Vignesh Ravi; Kyle Cheng; Daniel Q Bach; Scott Worswick
Journal:  Int J Dermatol       Date:  2020-02-13       Impact factor: 2.736

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.